Annual Shareholders Equity
$237.09 M
+$41.65 M+21.31%
December 31, 2023
Summary
- As of February 8, 2025, PRLD annual stockholders equity is $237.09 million, with the most recent change of +$41.65 million (+21.31%) on December 31, 2023.
- During the last 3 years, PRLD annual shareholders equity has risen by +$24.91 million (+11.74%).
- PRLD annual shareholders equity is now -17.07% below its all-time high of $285.90 million, reached on December 31, 2021.
Performance
PRLD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$156.43 M
-$25.84 M-14.18%
September 30, 2024
Summary
- As of February 8, 2025, PRLD quarterly stockholders equity is $156.43 million, with the most recent change of -$25.84 million (-14.18%) on September 30, 2024.
- Over the past year, PRLD quarterly shareholders equity has dropped by -$54.30 million (-25.77%).
- PRLD quarterly shareholders equity is now -56.13% below its all-time high of $356.57 million, reached on March 31, 2021.
Performance
PRLD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PRLD Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.3% | -25.8% |
| 3 y3 years | +11.7% | -20.0% |
| 5 y5 years | +1144.8% | -20.0% |
PRLD Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.1% | +21.3% | -45.3% | at low |
| 5 y | 5-year | -17.1% | +579.8% | -56.1% | +325.7% |
| alltime | all time | -17.1% | +579.8% | -56.1% | +325.7% |
Prelude Therapeutics Incorporated Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $156.43 M(-14.2%) |
| Jun 2024 | - | $182.28 M(-13.5%) |
| Mar 2024 | - | $210.73 M(-11.1%) |
| Dec 2023 | $237.09 M(+21.3%) | $237.09 M(-0.5%) |
| Sep 2023 | - | $238.26 M(-9.1%) |
| Jun 2023 | - | $262.06 M(+49.5%) |
| Mar 2023 | - | $175.30 M(-10.3%) |
| Dec 2022 | $195.44 M | $195.44 M(-10.1%) |
| Sep 2022 | - | $217.41 M(-9.7%) |
| Jun 2022 | - | $240.84 M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $261.81 M(-8.4%) |
| Dec 2021 | $285.90 M(+34.7%) | $285.90 M(-8.1%) |
| Sep 2021 | - | $311.24 M(-6.9%) |
| Jun 2021 | - | $334.36 M(-6.2%) |
| Mar 2021 | - | $356.57 M(+68.0%) |
| Dec 2020 | $212.18 M(-529.4%) | $212.18 M(-7.1%) |
| Sep 2020 | - | $228.31 M(-429.4%) |
| Jun 2020 | - | -$69.31 M(+40.3%) |
| Dec 2019 | -$49.41 M(+117.7%) | -$49.41 M |
| Dec 2018 | -$22.69 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual stockholders equity?
- What is the all time high annual shareholders equity for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual shareholders equity year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly shareholders equity year-on-year change?
What is Prelude Therapeutics Incorporated annual stockholders equity?
The current annual shareholders equity of PRLD is $237.09 M
What is the all time high annual shareholders equity for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual stockholders equity is $285.90 M
What is Prelude Therapeutics Incorporated annual shareholders equity year-on-year change?
Over the past year, PRLD annual stockholders equity has changed by +$41.65 M (+21.31%)
What is Prelude Therapeutics Incorporated quarterly stockholders equity?
The current quarterly shareholders equity of PRLD is $156.43 M
What is the all time high quarterly shareholders equity for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly stockholders equity is $356.57 M
What is Prelude Therapeutics Incorporated quarterly shareholders equity year-on-year change?
Over the past year, PRLD quarterly stockholders equity has changed by -$54.30 M (-25.77%)